Patient Gateway

RSS Feed

Yifeixiaoji decoction as an adjunct to osimertinib therapy in advanced EGFR-mutated NSCLC: protocol for a randomized, double-blind, placebo-controlled trial

Immunotherapy plus chemotherapy improves survival in SMARCA4-deficient NSCLC: a real-world cohort study

AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04

Impact of Surgical Resection on 5-Year Survival in Elderly NSCLC Patients: A SEER Database Analysis With Machine Learning-Based Predictive Modeling in Patients Aged ≥ 60 (2000–2021)

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC

Zipalertinib Plus Chemotherapy Meets PFS Endpoint in Phase 3 REZILIENT3 Trial for First-Line EGFR Exon 20–Mutant NSCLC

Adjuvant Selpercatinib in RET Fusion–Positive NSCLC

Rasha Aboelhassan: ASCO Living Guideline Update Adds Repotrectinib for NTRK-Positive NSCLC

Zipalertinib Combo Meets PFS End Point in First-Line EGFR Exon 20 NSCLC

In silico design of a novel therapeutic multi-epitope vaccine against NSCLC: a reverse vaccinology approach